GTS Stock Overview
Triple-S Management Corporation, through its subsidiaries, provides a portfolio of managed care and related products in the commercial, Medicare Advantage, and Medicaid markets.
Triple-S Management Competitors
Price History & Performance
|Historical stock prices|
|Current Share Price||US$35.53|
|52 Week High||US$36.33|
|52 Week Low||US$20.85|
|1 Month Change||1.05%|
|3 Month Change||0.17%|
|1 Year Change||55.70%|
|3 Year Change||95.73%|
|5 Year Change||68.76%|
|Change since IPO||146.51%|
Recent News & Updates
|GTS||US Healthcare||US Market|
Return vs Industry: GTS exceeded the US Healthcare industry which returned 19.1% over the past year.
Return vs Market: GTS exceeded the US Market which returned 21.3% over the past year.
|GTS Average Weekly Movement||0.8%|
|Healthcare Industry Average Movement||6.3%|
|Market Average Movement||5.9%|
|10% most volatile stocks in US Market||15.1%|
|10% least volatile stocks in US Market||2.2%|
Stable Share Price: GTS is less volatile than 75% of US stocks over the past 3 months, typically moving +/- 1% a week.
Volatility Over Time: GTS's weekly volatility has decreased from 8% to 1% over the past year.
About the Company
Triple-S Management Corporation, through its subsidiaries, provides a portfolio of managed care and related products in the commercial, Medicare Advantage, and Medicaid markets. It operates through three segments: Managed Care, Life Insurance, and Property and Casualty Insurance. The company offers various managed care products, including health maintenance organization plans; preferred provider organization plans; BlueCard program; Medicare Supplement products; Medicare Advantage products; Medicaid plans; and claims processing and other administrative services to employers, individuals, and government entities.
Triple-S Management Fundamentals Summary
|GTS fundamental statistics|
Is GTS overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|GTS income statement (TTM)|
|Cost of Revenue||US$3.39b|
Last Reported Earnings
Sep 30, 2021
Next Earnings Date
|Earnings per share (EPS)||3.45|
|Net Profit Margin||1.97%|
How did GTS perform over the long term?See historical performance and comparison
Is Triple-S Management undervalued compared to its fair value and its price relative to the market?
Price to Earnings (PE) ratio
Share Price vs. Fair Value
Below Fair Value: GTS ($35.53) is trading above our estimate of fair value ($29.68)
Significantly Below Fair Value: GTS is trading above our estimate of fair value.
Price To Earnings Ratio
PE vs Industry: GTS is good value based on its PE Ratio (10.3x) compared to the US Healthcare industry average (21.5x).
PE vs Market: GTS is good value based on its PE Ratio (10.3x) compared to the US market (17.2x).
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate GTS's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: GTS is good value based on its PB Ratio (0.8x) compared to the US Healthcare industry average (2.9x).
How is Triple-S Management forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?
Forecasted Healthcare industry annual growth in earnings
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Triple-S Management has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
How has Triple-S Management performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: GTS has high quality earnings.
Growing Profit Margin: GTS's current net profit margins (2%) are higher than last year (1.5%).
Past Earnings Growth Analysis
Earnings Trend: GTS's earnings have grown significantly by 30.8% per year over the past 5 years.
Accelerating Growth: GTS's earnings growth over the past year (49.6%) exceeds its 5-year average (30.8% per year).
Earnings vs Industry: GTS earnings growth over the past year (49.6%) exceeded the Healthcare industry 32.5%.
Return on Equity
High ROE: GTS's Return on Equity (8%) is considered low.
How is Triple-S Management's financial position?
Financial Position Analysis
Short Term Liabilities: GTS's short term assets ($619.2M) do not cover its short term liabilities ($1.5B).
Long Term Liabilities: GTS's short term assets ($619.2M) do not cover its long term liabilities ($634.7M).
Debt to Equity History and Analysis
Debt Level: GTS has more cash than its total debt.
Reducing Debt: GTS's debt to equity ratio has increased from 4.1% to 4.9% over the past 5 years.
Debt Coverage: GTS's debt is well covered by operating cash flow (272.5%).
Interest Coverage: GTS's interest payments on its debt are well covered by EBIT (13.2x coverage).
What is Triple-S Management current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Notable Dividend: Unable to evaluate GTS's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate GTS's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if GTS's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if GTS's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of GTS's dividend in 3 years as they are not forecast to pay a notable one for the US market.
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Bobby Garcia-Rodriguez (57 yo)
Mr. Roberto Garcia-Rodriguez, also known as Bobby, Esq., has been the Chief Executive Officer and President of Triple-S Management Corporation since January 1, 2016. Mr. Garcia-Rodriguez served as the Chie...
CEO Compensation Analysis
Compensation vs Market: Bobby's total compensation ($USD3.73M) is above average for companies of similar size in the US market ($USD2.26M).
Compensation vs Earnings: Bobby's compensation has been consistent with company performance over the past year.
Experienced Management: GTS's management team is seasoned and experienced (5.3 years average tenure).
Experienced Board: GTS's board of directors are considered experienced (6.3 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Triple-S Management Corporation's employee growth, exchange listings and data sources
- Name: Triple-S Management Corporation
- Ticker: GTS
- Exchange: NYSE
- Founded: 1959
- Industry: Managed Health Care
- Sector: Healthcare
- Market Cap: US$836.014m
- Shares outstanding: 23.53m
- Website: https://management.grupotriples.com
Number of Employees
- Triple-S Management Corporation
- 1441 F.D. Roosevelt Avenue
- San Juan
- Puerto Rico
- United States
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2021/11/26 23:10|
|End of Day Share Price||2021/11/26 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.